Clinical trial

MabionCD20® Compared to MabThera® in Patients With Rheumatoid Arthritis

NCT02468791

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-05-01

PhasePHASE3

Study timeline

Study start (actual)2013-05-01Date precision: month

Registry last updated2020-05-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

RituximabDRUG · verified · RxNorm: rituximab

Sponsors & collaborators

Mabion SAlead sponsor

Mapped research locations

WarsawPoland5 KharkivUkraine4 KrakowPoland3 PoznanPoland2 LublinPoland2 KyivUkraine2 BialystokPoland1 BydgoszczPoland1 BelgradeSerbia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02468791 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.